Plateforme GENOMAX

Jan 10, 2025 | link.springer.com | Japan Agency |Plateforme GENOMAX |Faculté de Médecine |Fédération Hospitalo-Universitaire OMICARE

AbstractThe optimal timing for initiating dialysis and prognostic markers in chronic kidney disease (CKD) patients are under debate, with mortality and cardiovascular risks varying among patients. This study investigates whether the apoptosis inhibitor of macrophage (AIM), which is mostly bound to pentameric IgM, could serve as an effective indicator. We prospectively followed 423 patients at dialysis initiation and 563 at various CKD stages.